Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2019 Apr 17;10:780. doi: 10.3389/fimmu.2019.00780

Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications

Hamid R Mirzaei 1, Analiz Rodriguez 2, Jennifer Shepphird 3, Christine E Brown 3, Behnam Badie 2,*
PMCID: PMC6479719  PMID: 31049049

In the original article, there was an error. We neglected to disclose a conflict of interest.

A correction has been made to the Conflict of Interest statement:

“Patents associated with CAR design, T cell manufacturing, and delivery have been licensed by Mustang Bio., Inc., for which CB and BB receive licensing and consulting payments.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES